Desitin Arzneimittel Gmbh
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Private
- Established
- 1919-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.desitin.de
Clinical Trials
20
Active:8
Completed:11
Trial Phases
3 Phases
Phase 1:10
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 1
10 (76.9%)Phase 3
2 (15.4%)Phase 2
1 (7.7%)Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets
Phase 1
Completed
- Conditions
- Multiple Drug Use
- Interventions
- Drug: Sodium valproate 500 MGDrug: Valproic Acid 500 MG
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2024-01-23
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 22
- Registration Number
- NCT06214130
- Locations
- 🇨🇦
Biopharma Services INC, Toronto, Canada
Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 28
- Registration Number
- NCT06211283
- Locations
- 🇨🇦
Biopharma Services INC, Toronto, Canada
Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 24
- Registration Number
- NCT06199791
- Locations
- 🇨🇦
Biopharma Services INC, Toronto, Canada
Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
- First Posted Date
- 2022-02-11
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 298
- Registration Number
- NCT05236842
- Locations
- 🇧🇪
Pneumocare SRL, Namur, Belgium
Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration
Phase 1
Completed
- Conditions
- Fasted State
- Interventions
- First Posted Date
- 2014-04-17
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 12
- Registration Number
- NCT02116465
- Locations
- 🇧🇬
Department of Clinical Pharmacology, Sofia, Bulgaria
- Prev
- 1
- 2
- 3
- Next
News
No news found